DUBLIN–(BUSINESS WIRE)–Research and Markets (http://www.researchandmarkets.com/research/zw29tf/rhinoconjunctivit) has announced the addition of the “Rhino-Conjunctivitis-Pipeline Insights, 2016” report to their offering. Rhino-Conjunctivitis-Pipeline…
Category: News
Inotek Pharmaceuticals to Present at Glaucoma 360 New Horizons Forum
LEXINGTON, Mass.–(BUSINESS WIRE)–Cadmus Rich, MD, Vice President, Medical Affairs and Clinical Development of Inotek, will present at Glaucoma 360: New Horizons Forum on Friday, January 29, 2016 at the Palace Hotel in San Francisco.
Uncorrected hyperopia may affect reading ability among preschoolers
A study funded by the National Eye Institute, part of the National Institutes of Health, has shown that uncorrected farsightedness (hyperopia) in preschool children is associated with significantly worse performance on a test of early literacy.
Edited stem cells offer hope of precision therapy for blindness
Findings raise the possibility of treating blinding eye diseases using a patient’s own corrected cells as replacement tissue.
CUMC, Iowa scientists use CRISPR to repair genetic mutation responsible for retinitis pigmentosa
Columbia University Medical Center and University of Iowa scientists have used a new gene-editing technology called CRISPR, to repair a genetic mutation responsible for retinitis pigmentosa (RP), an inherited condition that causes the retina to degrade…
Q&A With Detroit’s New Director of Public Health
(MedPage Today) — Abdul El Sayed, MD, is optimistic about reinventing a collapsed system
What Would Single-Payer Mean for Doctors?
(MedPage Today) — Experts outline the pros and cons
Current Therapeutic Developments in Atrophic AMD
More effective therapies are on the horizon for atrophic AMD. Find out what’s new. The British Journal of Ophthalmology
Farsighted kids’ reading skills fall behind before they start first grade
Kids with uncorrected farsightedness lose ground on reading skills before they ever start first grade, a new study has found.
Let’s Turn the ‘Triple Aim’ into the ‘Quadruple Aim’
(MedPage Today) — Clinician well-being needs to be considered too, says Yul Ejnes, MD
Recent Expansion of Columbia Eye Consultants Optometry Staff and Facilities Pave the Way for Additional Growth
COLUMBIA, Mo.–(BUSINESS WIRE)–Recent expansion of Columbia Eye Consultants Optometry staff and facilities pave the way for additional growth in 2016
Intraocular Lens Pipeline Yields Increasing Options
In addition to existing premium lenses, each with unique advantages and disadvantages, ophthalmologists will soon have access to even more promising technologies for treating presbyopia. Medscape Ophthalmology
S. aureus can spread from blood to eye, endangering vision
Nearly ten percent of cases of Staphylococcus aureus infections of the blood spread to the eyeball, according to a team of Korean clinical investigators.
Ranibizumab Treat-and-Extend Regimen May Be Better for Neovascular AMD
A ranibizumab treat-and-extend regimen appears to be better than a pro re nata (PRN) regimen for treating neovascular age-related macular degeneration (AMD), according to researchers from Switzerland. Reuters Health Information
Refractive Outcomes Stable at Five Years After SMILE Procedure for Myopia
Refractive outcomes remain stable at five years in the first eyes treated with small incision lenticule extraction (ReLEx SMILE, Zeiss) for myopia, report ophthalmologists from Germany. Reuters Health Information
Senators Vent Frustration With ACA Co-op Program
(MedPage Today) — Committee chair says CMS encouraged co-ops to “cook the books”
Breakthrough discovery in the genetics of corneal dystrophies
Researchers at the UCL Institute of Ophthalmology and Moorfields Eye Hospital London, in collaboration with colleagues in the Czech Republic, have discovered a new genetic cause of corneal…
Study: sight loss patients with depression are “routinely overlooked”
A new study has revealed that nearly half of people attending NHS low vision clinics for help with sight loss suffer from symptoms of clinical depression – but they are not being diagnosed or given…
The ACA Will Take Time — But It’s Worth the Wait
(MedPage Today) — The ACA will ultimately insure more people and improve healthcare
The Levi’s® Brand Taps FGX International Inc. as its New Licensee Eyewear Partner
SMITHFIELD, R.I.–(BUSINESS WIRE)–FGX International, a leading eyewear designer and marketer, announced today they have teamed up with the Levi’s® brand to launch a unisex collection of branded Levi’s® eyewear for both sunglasses and optical frames. In the substantial and growing market of sunglasses and optical frames, the FGX International and Levi’s® collaboration will leverage FGX’s impressive 85 year heritage and market expertise of producing eyewear, and the long standing legacy of Levi